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The midgut environment of anopheline mosquitoes plays an important role in the development of the malaria
parasite. Using genetic manipulation of anopheline mosquitoes to change the environment in the mosquito midgut
may inhibit development of the malaria parasite, thus blocking malaria transmission. Here we generate transgenic
Anopheles stephensi mosquitoes that express the C-type lectin CEL-III from the sea cucumber, Cucumaria echinata,i na
midgut-specific manner. CEL-III has strong and rapid hemolytic activity toward human and rat erythrocytes in the
presence of serum. Importantly, CEL-III binds to ookinetes, leading to strong inhibition of ookinete formation in vitro
with an IC50 of 15 nM. Thus, CEL-III exhibits not only hemolytic activity but also cytotoxicity toward ookinetes. In these
transgenic mosquitoes, sporogonic development of Plasmodium berghei is severely impaired. Moderate, but significant
inhibition was found against Plasmodium falciparum. To our knowledge, this is the first demonstration of stably
engineered anophelines that affect the Plasmodium transmission dynamics of human malaria. Although our
laboratory-based research does not have immediate applications to block natural malaria transmission, these findings
have significant implications for the generation of refractory mosquitoes to all species of human Plasmodium and
elucidation of mosquito–parasite interactions.
Citation: Yoshida S, Shimada Y, Kondoh D, Kouzuma Y, Ghosh AK, et al. (2007) Hemolytic C-type lectin CEL-III from sea cucumber expressed in transgenic mosquitoes impairs
malaria parasite development. PLoS Pathog 3(12): e192. doi:10.1371/journal.ppat.0030192
Introduction
Malaria, transmitted by anopheline mosquitoes, is among
the worst health problems in the world, killing 1–2 million
people every year, mostly African children. Lack of an
effective vaccine and the emergence of Plasmodium strains
resistant to many existing anti-malarial drugs have aggravated
this situation. Therefore, the control of vector competence
has become a more important target in malaria intervention.
Recent advances in genetic engineering of anopheline
mosquitoes have raised hopes for their use as new strategies
for malaria control, also the provision of powerful tools for
investigating mosquito-parasite interactions. We and others
have characterized tissue-speciﬁc promoters that drive robust
expression of transgenes in the midgut [1,2], hemocoel [3],
and salivary glands [4]. The next challenge is to identify
‘‘effector’’ molecules to inhibit development of malaria
parasites without competitive cost to the mosquito. To date,
several effector molecules have been identiﬁed (e.g., single-
chain antibody fragments directed against parasite ligands
[5,6], the dodecapeptide SM1 [7], PLA2 [8], a cecropin-like
peptide [9], and the Vida3 peptide [10]; (see reviews [11,12]).
Of these, transgenic mosquitoes expressing either SM-1 or
PLA2 in a midgut-speciﬁc manner were less able to support
transmission of the rodent parasite P. berghei [13,14]. How-
ever, the SM1 transgenic mosquito was not resistant to the
human malaria parasite P. falciparum (M. Jacobs-Lorena,
unpublished observations), and the PLA2 transgenic mosqui-
to was signiﬁcantly less ﬁt than the wild-type [15]. In those
transgenic mosquitoes generated so far, no single effector
molecule has exhibited a ‘‘non-sporozoite’’ phenotype in the
salivary glands, i.e., complete Plasmodium transmission block-
ade. Therefore, other effector molecules and/or mechanisms
are required to generate a transgenic mosquito that is both ﬁt
and refractory to all species and strains of human Plasmodium.
Transmission of malaria parasites is absolutely dependent
on availability of competent mosquito vectors. Development
of Plasmodium in the mosquito begins with ingestion of an
infectious blood meal containing gametocytes from a verte-
brate host [16]. In the mosquito midgut lumen, female and
male gametocytes mature into gametes after exposure to
environmental and mosquito-speciﬁc factors. These include a
drop in temperature of 5 8C and exposure to xanthurenic acid
[17]. A signal transduction cascade results in the release of
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initiating development and its escape from the erythrocyte
[18]. After fertilization, the zygote matures into a motile
ookinete. Anopheline mosquitoes rapidly concentrate the
contents of the blood meal 1.5- to 2-fold, resulting in highly
viscous gut content. Although little is known about the
inﬂuence of these changes, we postulated that changes to the
midgut environment could inhibit parasite development. We
chose to express the CEL-III lectin from the sea cucumber,
Cucumaria echinata. CEL-III is a Ca
2þ-dependent (C-type) lectin,
that exhibits strong hemolytic and cell-dependent activity [19]
as well as cytotoxicity toward some cultured cell lines [20] by
forming ion-permeable pores in target cell membranes
through oligomerization after binding to carbohydrate chains
on the cell surface [21,22]. Furthermore, synthetic peptides
derived from the C-terminal hydrophobic region of CEL-III
exhibit strong activity against Gram-positive bacteria such as
Staphylococcus aureus and Bacillus subtilis [23].
Here we show that CEL-III strongly inhibits ookinete
formation in vitro, and transgenic mosquitoes expressing
CEL-III in the midgut signiﬁcantly inhibit oocyst formation
and sporozoite production, not only of P. berghei but also P.
falciparum. To our knowledge, this is the ﬁrst demonstration
of stably engineered anophelines in which the reduction of
vectorial capacity transcends Plasmodium species.
Results
Hemolytic and Hemagglutination Activities of CEL-III Are
Directed Toward Human and Rat Erythrocytes, but Not
Mouse Erythrocytes
CEL-III has strong Ca
2þ-dependent hemolytic activity
toward human and rabbit erythrocytes, but shows only weak
hemagglutination of chicken and horse erythrocytes [24]. This
species-speciﬁc hemolysis is due to the binding of CEL-III to
speciﬁc carbohydrate receptors on the erythrocyte surface.
We examined whether CEL-III has hemolytic and hemagglu-
tination activities toward mouse and rat erythrocytes as hosts
for the rodent malaria parasite P. berghei. Figure 1A and 1B
Figure 1. Hemolytic and Hemagglutination Activities of CEL-III toward Human, Mouse, and Rat Erythrocytes
(A) Serial 2-fold dilutions of CEL-III were mixed with human, mouse, or rat erythrocytes in V-shaped microtiter plate wells. Samples were incubated in the
absence ( ) or presence (þ) of 5% FBS. Hemolysis was examined visually after incubation for 1 h at room temperature.
(B) Hemolytic activity toward human, mouse, and rat erythrocytes was expressed as the absorbance at 550 nm resulting from release of hemoglobin.
(C) Serial 2-fold dilutions of CEL-III were mixed with human, mouse, or rat erythrocytes in V-shaped microtiter plate wells. Samples were incubated in the
presence of 10% Dextran 4. Agglutination was examined visually after incubation for 1 h at room temperature.
(D) CEL-III was added to mouse (panels 1 and 2) or rat erythrocytes (panels 3 and 4), and bound CEL-III was detected with FITC-labeled anti-mouse IgG
following mouse anti-CEL-III antibody by fluorescence microscopy. Panels 1 and 3, phase contrast; panels 2 and 4, FITC. Scale bars are 10 lm.
doi:10.1371/journal.ppat.0030192.g001
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CEL-III Transgenic Mosquito
Author Summary
Malaria is arguably the most important vector-borne disease
worldwide, affecting 300 million people and killing 1–2 million
people every year. The lack of an effective vaccine and the
emergence of the parasites’ resistance to many existing anti-malarial
drugs have aggravated the situation. Clearly, development of novel
strategies for control of the disease is urgently needed. Mosquitoes
are obligatory vectors for the disease and inhibition of parasite
development in the mosquito has considerable promise as a new
approach in the fight against malaria. Based on recent advances in
the genetic engineering of mosquitoes, the concept of generating
genetically modified (GM) mosquitoes that hinder transmission by
either killing or interfering with parasite development is a potential
means of controlling the disease. To generate these GM mosquitoes,
the authors focused on a unique lectin isolated from the sea
cucumber, which has both hemolytic and cytotoxic activities, as an
anti-parasite effector molecule. A transgenic mosquito expressing
the lectin effectively caused erythrocyte lysis in the midgut after
ingestion of an infectious blood meal and severely impaired parasite
development. This laboratory-acquired finding may provide signifi-
cant implications for future malaria control using GM mosquitoes
refractory to the parasites.shows that the hemolytic activity of CEL-III was strong toward
human and rat erythrocytes at low concentrations (IC50¼0.3
and 0.8 lg/ml, respectively) in the presence of 5% fetal bovine
serum (FBS: a source of Ca
2þ), whereas there was no hemolytic
activity toward mouse erythrocytes. Weak hemolytic activity
was observed against human and rat erythrocytes even in the
absence of FBS. Similarly, CEL-III exhibited strong hemag-
glutination activity toward human and rat erythrocytes, but
not toward mouse erythrocytes (Figure 1C). Fluorescent
microscopic studies also conﬁrmed that CEL-III bound to
rat erythrocytes with numerous punctuate dots distributed
throughout the cells, whereas no signals were detected in
mouse erythrocytes (Figure 1D). These results suggest that
carbohydrate chains on the mouse and rat erythrocyte
surface may differ.
In Vitro Effect of CEL-III on Ookinete Development
It has been reported that CEL-III is cytotoxic toward some
cultured cell lines as well as toward erythrocytes [20].
Therefore, we investigated the effect of CEL-III on ookinete
development in vitro. At ﬁrst, CEL-III was added to cultured
ookinetes in the absence of Ca
2þ. Figure 2A shows that bound
CEL-III was observed as small punctuate dots distributed
throughout the ookinete (similar the binding of CEL-III to rat
erythrocytes as shown in Figure 1D), whereas no signals were
detected in the ookinete without CEL-III. Next, CEL-III was
incubated with gametocytes in vitro and the number of
ookinetes was determined 24 h later. Figure 2B shows that
CEL-III (10 lg/ml) inhibited ookinete development by
approximately 95%. This inhibition was dose-dependent,
with an IC50 of approximately 15 nM.
CEL-III Is Expressed in the Midgut of Transgenic
Mosquitoes
To express CEL-III in the A. stephensi midgut, we made a
pAgCP-CEL-III gene cassette consisting of the promoter, 59-
UTR, and signal peptide from the A. gambiae carboxypepti-
dase A (AgCPA) gene [1] linked to the coding sequence of the
CEL-III gene that lacked signal peptide sequence and the
anopheles trypsin 1 (Antryp1) putative terminator region
(Figure 3A). This gene cassette was inserted into pMinos-
EGFP-RfA-F to construct pMinos-EGFP-carboxypeptidaseP-
Figure 2. Binding of CEL-III to Ookinetes Inhibits Parasite Development
In Vitro
(A) Binding of CEL-III to ookinetes. CEL-III was added to cultured
ookinetes purified from P. berghei–infected mouse blood. Bound CEL-III
was detected with FITC-labeled anti-mouse IgG following mouse anti-
CEL-III antibody by fluorescence microscopy (panels 1 and 2) (CEL-III (þ)).
As a negative control, ookinetes were incubated with FITC-labeled anti-
mouse IgG following mouse anti-CEL-III antibody without CEL-III (panels
3 and 4) (CEL-III ( )). Panels 1 and 3, phase contrast; panels 2 and 4, FITC.
Arrows indicate cultured ookinetes. Scale bars are 10 lm.
(B) Effect of CEL-III on ookinete development in vitro. P. berghei–infected
mouse blood was cultured for ookinetes for 24 h at 19 8C. CEL-III was
added at initiation of the culture at various concentrations. Data are
expressed as number of ookinetes relative to medium alone (100%).
Results are the mean of two independent experiments, and bars
represent standard errors of the mean.
doi:10.1371/journal.ppat.0030192.g002
Figure 3. Structure of the CEL-III Gene and Its Expression in Transgenic
Mosquitoes
(A) Schematic diagram of the pMinos-EGFP-carboxypeptidaseP-CELIII-
antryp1T construct used for A. stephensi germ line transformation. The
construct consists of the D. melanogaster actin5c promoter (actinP), egfp
selectable marker (egfp), and D. melanogaster hsp70 terminator
sequence (hspT), the A. gambiae carboxypeptidase promoter sequence
(agcpP) plus its signal sequence (SP), fused in-frame to the coding
sequence of CEL-III without its signal sequence followed by the A.
gambiae trypsin terminator sequence (trypT). The left (ML) and right (MR)
arms of Minos are indicated by triangles.
(B) Induction of CEL-III mRNA by a blood meal. Transgenic mosquitoes
were allowed to feed on a non-infected mouse and 6 h later total RNA
was extracted from midguts of engorged mosquitoes (Blood-fed). As a
control, total RNA was extracted from midguts of sugar-fed mosquitoes
(Sugar-fed). CEL-III mRNA level was examined using RT-PCR. PCR
products of the endogenous carboxypeptidase gene and the S7 gene
were used as inducible positive controls and quantitative controls of the
different mRNA preparations, respectively. These PCR products were
fractionated by electrophoresis then stained with ethidium bromide.
(C) Hemolytic activity of midgut contents of transgenic mosquitoes.
Transgenic (CEL-III) and non-transgenic (WT) mosquitoes were offered a
serum meal by membrane feeding. Six h after the meal, the supernatants
of midgut lysates were added to human erythrocytes. Hemolytic activity
was determined by visual examination of lysis of erythrocytes as
described in Figure 1A.
doi:10.1371/journal.ppat.0030192.g003
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CEL-III Transgenic MosquitoCELIII-antryp1T, then transformed into the germ line of A.
stephensi embryos. A total of 876 embryos were injected and 22
fertile G0 matings were obtained. From these, one mating
produced transgenic offspring expressing the egfp selectable
marker. A transgenic homozygous line was obtained and
propagated. A single integration event was conﬁrmed by
Southern blot analysis using genomic DNA from G4 adults
(data not shown). The transgenic line has been stably
maintained by blood feeding on mice or rats for over 30
generations, with no difference in reproductive ﬁtness
between transgenic and non-transgenic mosquitoes (i.e.,
number of eggs and hatched larvae; data not shown).
Expression proﬁles of the CEL-III transgene were inves-
tigated by real-time (RT)-PCR (Figure 3B). CEL-III mRNA was
present in the midgut cells of sugar-fed mosquitoes and was
strongly induced 6 h after blood ingestion, consistent with the
pattern of expression of the endogenous A. stephensi carbox-
ypeptidase A (AsCPA) gene, which is similar expression
pattern to that of the AgCPA gene [25]. To examine whether
CEL-III is secreted into the midgut lumen upon blood
ingestion, transgenic mosquitoes were offered a serum meal
by membrane feeding. Midgut lysates of the transgenic
mosquitoes before and after the serum meal contained
hemolytic activity toward human erythrocytes, but not in
those of non-transgenic mosquitoes, indicating CEL-III is
secreted into the midgut lumen upon feeding (Figure 3C).
Immunoblot analysis detected monomeric (48 kDa) and
oligomeric (.200 kDa) forms of CEL-III in the midguts of
sugar-fed transgenic mosquitoes (Figure 4). The relative
mobilities of these two forms were similar to those of native
CEL-III. In mosquitoes offered a blood-free ATP meal as a
phagostimulant, the AgCPA promoter is activated [25,26].
Under these conditions, a slightly enhanced expression of the
oligomeric form was observed 24 h after the meal. Compared
to the native CEL-III, we estimate 5–10 ng of CEL-III
accumulated in a single midgut after the ATP meal.
Transgenic Mosquitoes Completely Hemolyze Human
Erythrocytes 24 h after a Blood Meal
We conﬁrmed hemolysis of human erythrocytes 24 h after a
blood meal in midgut sections of a transgenic mosquito.
Mosquitoes were allowed to feed on a human, then, 24 h after
the blood feeding, gut sections were prepared for histology
and stained with hematoxylin and eosin (HE). Compared to
non-transgenic midguts which were ﬁlled with intact eryth-
rocytes (Figure 5A and 5C), erythrocytes in the midgut of
transgenic mosquito were extensively hemolyzed (Figure 5B
and 5D). Lymphocytes were clearly contrasted in the midgut
of transgenic mosquito (Figure 5D), but not amongst the
intact erythrocytes in the midgut of non-transgenic mosquito
(Figure 5C). These results are consistent with the data shown
in Figure 3C, where the secretion of CEL-III into the midgut
lumen caused effective hemolysis.
Transgenic Mosquitoes Impair P. berghei Oocyst
Formation in Both Rat and Mouse Models
To investigate the effect of CEL-III expression on P. berghei
development, both transgenic and non-transgenic mosqui-
toes were allowed to feed on the same P. berghei–infected rat
and the number of oocysts formed was counted. In three
experiments, the infection rate (prevalence) of transgenic
mosquitoes (10.5%) was markedly reduced compared to non-
transgenic mosquitoes (63.6%) (transmission blockade of
prevalence, TBp; 83.5%, p , 0.01). The oocyst numbers were
consistently and strongly lower in transgenic mosquitoes
Figure 4. CEL-III Expression in Midguts of Transgenic Mosquitoes
Transgenic (CEL-III) and non-transgenic (WT) mosquitoes were allowed to
feed on naı ¨ve mice. After 6 or 24 h, midguts of engorged mosquitoes
were dissected and lysed, then electrophoresed on 8% SDS-PAGE. As a
control, midguts of sugar-fed mosquitoes (S) were dissected and lysed.
CEL-III expression level was examined by western blotting using mouse
anti-CEL-III antiserum. Each lane contains protein lysates equivalent to
two midguts. The source of protein is indicated at the top of each lane (6,
24 h). For quantitative estimation of CEL-III per midgut, native CEL-III
isolated from C. echinata body fluid was analyzed by western blotting.
The amount of native CEL-III (5, 25, 100 ng) is indicated at the top of each
lane. Arrows indicate the positions of monomeric and oligomeric forms
of CEL-III.
doi:10.1371/journal.ppat.0030192.g004
Figure 5. Hemolysis of Human Blood in Mosquito Midgut
Mosquitoes were allowed to feed on a human volunteer. Representative
photomicrographs of engorged mosquito gut sections 24 h after a blood
meal are shown (HE staining,340 magnification for [A and B], and31,000
magnification for [C and D]). Midgut of non-transgenic mosquitoes was
filled with intact erythrocytes (A and C), with many spaces between
erythrocytes. In contrast, no space is observed in the midgut of
transgenic mosquitoes (B and D). Erythrocytes appear to be completely
hemolyzed, and HE-stained lymphocytes cells are detectable (arrows).
Scale bars in (A and B) and (C and D) are 500 lm and 10 lm, respectively.
doi:10.1371/journal.ppat.0030192.g005
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CEL-III Transgenic Mosquito(transmission blockade of intensity, TBi; range 90.0 to 97.9%,
mean 90.5%, p , 0.01) (Table 1). For mouse experiments, TBp
in Experiment 1 and TBi in both experiments were
signiﬁcantly reduced in transgenic mosquitoes. Overall, the
two experiments combined, both TBp and TBi were
signiﬁcantly reduced in transgenic mosquitoes (p , 0.01)
(Table 2).
Vector Competence for P. berghei in Transgenic
Mosquitoes Is Reduced
The impact of CEL-III expression on the ability of
mosquitoes to transmit the parasite to uninfected animals
(vectorial competence) was measured (Table 3). Vectorial
competence of transgenic mosquitoes (20%) was severely
impaired, compared to non-transgenic mosquitoes (100%).
After a blood meal, the salivary glands of engorged
mosquitoes were dissected, and numbers of sporozoites were
counted. The number of sporozoites in individual salivary
glands of the transgenic mosquitoes was markedly lower than
that of non-transgenic mosquitoes. Importantly, sporozoite
prevalence in transgenic mosquitoes (10%) was signiﬁcantly
reduced compared to non-transgenic mosquitoes (60%)
(Table 4). These data reﬂect the oocyst prevalence seen in
the rat experiments (Table 1).
Transgenic Mosquitoes Impair Oocyst Formation of P.
falciparum
To investigate the effect of CEL-III expression on human
Plasmodium development, both transgenic and non-transgenic
mosquitoes were allowed to feed on mature P. falciparum
gametocyte cultures by membrane feeding, followed by
determination of the number of oocysts formed (Table 5).
In Experiment 1, oocyst formation in transgenic mosquitoes
was signiﬁcantly impaired (TBi 76.6%). In Experiment 2, TBi
was 57.1%, and there was no statistically signiﬁcant difference
between transgenic and non-transgenic mosquitoes. Most
likely, the low infection prevalence (30%) and low oocyst
number (0.7 6 1.4) in Experiment 2 affected the statistical
analysis. Overall, with the two experiments combined, trans-
genic mosquitoes signiﬁcantly impaired P. falciparum oocyst
numbers (TBi 69.1%, p , 0.05), although TBp was only 7.8%.
Discussion
This study demonstrates a novel ‘‘proof-of-concept’’ show-
ing that transgenic mosquitoes expressing C-type lectin CEL-
III signiﬁcantly impairs development of both P. berghei and P.
falciparum. We hypothezised that an environmental change in
the midgut of anopheline mosquitoes by genetic manipu-
Table 1. Rat–P. berghei Experiments
Experiment Mosquitoes Prevalence
a TBp
b Number Oocysts/Gut
c (Range) TBi
d
1 Control 72.7% (8/11) — 4.3 6 6.5 (0–22) —
CEL-III 9.4% (3/32) 87.1%
e 0.4 6 1.6 (0–8) 90.7%
e
2 Control 58.3% (14/24) — 4.0 6 7.5 (0–28) —
CEL-III 14.3% (2/14) 75.5%
f 0.4 6 1.2 (0–8) 90.0%
e
3 Control 66.7% (6/9) — 4.7 6 6.6 (0–20) —
CEL-III 9.1% (1/11) 86.4%
f 0.1 6 0.3 (0–1) 97.9%
e
Average Control 63.6% (28/44) — 4.2 6 6.9 (0–28) —
CEL-III 10.5% (6/57) 83.5%
e 0.4 6 1.3 (0–8) 90.5%
e
Transgenic (CEL-III) and non-transgenic (control) mosquitoes were fed on the same P. berghei–infected rats. On day 15, the guts were dissected and the number of oocysts per gut was
determined.
aPercentage of infected mosquitoes (actual numbers in parentheses).
bTransmission blockade of prevalence (TBp) ¼ 100   [(prevalence of transgenic mosquitoes)/(prevalence of control mosquitoes) 3 100].
cThe number of oocysts per midgut (intensity) are shown as means 6 SEM.
dTansmission blockade of intensity (TBi) ¼ 100   [(average oocyst number per gut in transgenic mosquitoes/ average oocyst number per gut in control mosquitoes) 3 100].
eStatistical significance (p , 0.01), as calculated by the Mann-Whitney U test.
fStatistical significance (p , 0.05), as calculated by the Mann-Whitney U test.
doi:10.1371/journal.ppat.0030192.t001
Table 2. Mouse–P. berghei Experiments
Experiment Mosquitoes Prevalence
a TBp
b Number Oocysts/Gut
c (Range) TBi
d
1 Control 83.3% (15/18) — 50.2 6 78.9 (0–300) —
CEL-III 44.0% (11/25) 47.2%
f 10.6 6 22.3 (0–100) 78.9 %
e
2 Control 75.0% (12/16) — 58.3 6 68.3 (0–217) —
CEL-III 33.3% (4/12) 55.6% 3.3 6 7.1 (0–24) 94.3%
e
Average Control 79.4% (27/34) — 54.0 6 73.1(0–300) —
CEL-III 40.5% (15/37) 49.0%
e 8.2 6 18.9 (0–100) 84.8%
e
Transgenic (CEL-III) and non-transgenic (control) mosquitoes were fed on the same P. berghei–infected mice. On day 15, the guts were dissected and the number of oocysts per gut was
determined.
a, b, c, dPrevalence, TBp, intensity, and TBi are described as Table 1.
eStatistical significance (p , 0.01), as calculated by the Mann-Whitney U test.
fStatistical significance (p , 0.05), as calculated by the Mann-Whitney U test.
doi:10.1371/journal.ppat.0030192.t002
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CEL-III Transgenic Mosquitolation could provide a new strategy for interrupting parasite
development. CEL-III is a C-type, galactose/N-acetylgalactos-
amine (GalNAc)-speciﬁc lectin isolated from the body ﬂuid of
the marine invertebrate C. echinata. This lectin exhibits strong
and rapid hemolytic activity and cytotoxicity through pore
formation in target cell membranes. CEL-III is thought to
play an important role in innate defense systems of C. echinata
and therefore has the potential not only to change the
environment of the mosquito midgut by rapid hemolysis of a
blood meal, but also to act directly as a toxin against
parasites.
For CEL-III, the N-terminal region contains two carbohy-
drate binding domains that have homology with the B-chains
of ricin and abrin [20,27,28] and binds to the carbohydrate
chains on the surface of the target cell membrane by its lectin
activity. The C-terminal hydrophobic region that has anti-
bacterial activity is believed to permeabilize the lipid bilayer
of target microbes and cells [23]. CEL-III may therefore
exhibit direct effector function to kill parasites. Alternatively,
similar to other antimicrobial peptides or lectins, CEL-III
may induce cells to undergo apoptosis [29].
In the transgenic mosquitoes, CEL-III is constitutively
expressed prior to blood meal ingestion and accumulates in
the midgut. Expression level of CEL-III was enhanced and
reached a peak at 5–10 ng per midgut after a protein-free
ATP meal. This amount is sufﬁcient to completely hemolyze
human erythrocytes in 3 ll-whole blood. As A. stephensi usually
imbibes in less than 2.2 ll in a single blood meal [30], this
result is consistent with the observation that complete
hemolysis occurred in the midgut at 24 h after a blood meal.
Within minutes of ingestion, both male and female
gametocytes escape from enveloping erythrocytes, then
transform into male and female gametes. The male gametes
produce eight ﬂagellate microgametes in a process termed
exﬂagellation, fertilizing the female gametes, giving rise ﬁrst
to zygotes then motile ookinetes. In the rat model, CEL-III
accumulation in the midgut before a blood meal is likely to
hemolyze erythrocytes infected with gametocytes immedi-
ately after a blood meal. As a result, extracellular gametocytes
may be killed before differentiation. Although CEL-III cannot
cause hemolysis of mouse erythrocytes, oocyst formation was
also signiﬁcantly reduced in the mouse model suggesting that
direct parasite toxicity may be the dominant impact of the
peptide. Preliminary observations suggest CEL-III reduces the
efﬁciency of fertilization (S.Y. unpublished data). Addition-
ally CEL-III bound to cultured ookinetes correlating with a
strong killing effect on the parasites (IC50¼15 nM) at 100- to
1,000-fold lower concentrations in vitro, when compared to
other reported effector molecules, such as cecropin-like
peptide [9], defensin [31], Vida3 [10], SM1 [7], and PLA2 [8].
In the rat model, the higher TBi (90.5%) may be due to
additional hemolysis compared to that of the mouse model
(84.8%). Although the binding speciﬁcity and mechanism by
which CEL-III kills parasites in mosquitoes is unknown,
ﬁndings from this study suggest that CEL-III may cause lethal
damage to the female gamete and ookinete by pore formation
following oligomer formation.
For P. berghei, the key property, as proposed in 1968 by
Curtis [32], of vectorial competence was demonstrably and
severely impaired, as measured by the relative inefﬁciency of
transgenic mosquitoes to infect naı ¨ve mice compared to wild-
type. Importantly, CEL-III transgenic mosquitoes impair
sporogonic development of P. falciparum. To our knowledge,
this is the ﬁrst demonstration of stably engineered anophe-
lines that affect the human Plasmodium transmission dynamics
of a human malaria. Compared to the P. berghei-rat model, the
TBi of P. falciparum is numerically lower (69.1%). One possible
explanation for the lower TBi is that membrane feeding of in
vitro cultured P. falciparum gametocytes does not contain
leukocytes that may remain active in the mosquito blood
meal and kill or phagocytose the liberated extracellular
parasites [33,34].
In malaria endemic areas, multiple infections with Plasmo-
dium species and strains are often observed. Those effector
gene products must inhibit development of all species and
strains of Plasmodium in the mosquito. As CEL-III targets
erythrocytes, the ‘‘vehicles’’ for this parasite, as well as
ookinetes, this transgenic mosquito may prove to be
refractory to all species and strains of Plasmodium, including
P. falciparum and P. vivax. Transgenic mosquitoes must have a
minimal ﬁtness cost, as such costs would reduce the
effectiveness of the genetic drive mechanisms used to
introduce transgenes into ﬁeld mosquito populations. To
date, there have been no single or cumulative toxic effects
Table 3. Vectorial Competence of Transgenic Mosquitoes
% Infected Mice
b
(Number of Infected/Total)
Control CEL-III
Vector competence
a
(3   mosquito bites/mouse  6)
100% (10/10) 20% (1/5)
Transgenic (CEL-III) and non-transgenic (control) mosquitoes were fed on the same P.
berghei–infected rat. To measure transmission, three to six mosquitoes were fed on
individual naı ¨ve mice 21 days after the infectious blood meal.
aSix mosquitoes were allowed to feed on individual naı ¨ve mice 21 days after ingesting the
infectious blood meal. Of six mosquitoes, at least three mosquitoes were observed to feed
on each mouse.
bThe infection status of each mouse was established by examining a smear of tail vein
blood on alternate days. Mice that had no parasites by day 30 were considered to be non-
infected.
doi:10.1371/journal.ppat.0030192.t003
Table 4. Sporozoite Infectivity of Salivary Glands of Transgenic
Mosquitoes
Number of Sporozoites (spz)/
Salivary Glands
a
Number of Mosquitoes
Control CEL-III
02 4 1 8
1   spz   500 12 1
500 , spz   5,000 19 1
5,000 , spz 5 0
% Infected mosquitoes (Number infected/total) 60% (36/60) 10% (2/20)
b
Immediately after blood feeding (Table 3), engorged mosquitoes (20 transgenic and 60
non-transgenic mosquitoes) were picked up and the salivary glands were dissected and
the number of sporozoites per salivary gland was determined.
aIndividual salivary glands were observed for sporozoites by phase contrast microscopy
after crushing the glands under a cover slip and the number of sporozoites were counted
and scored.
bThe number of sporozoites was significantly lower (p , 0.001) in transgenic than in non-
transgenic mosquitoes, as calculated by the Mann-Whitney U test.
doi:10.1371/journal.ppat.0030192.t004
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ity (eggs laid per female). Further studies are nevertheless
required to address the ability of CEL-III transgenic
mosquitoes to compete with their non-transgenic siblings.
While we have demonstrated it is possible to create
mosquitoes with impaired vectorial competence for more
than one species of malarial parasites, we recognize there are
numerous other scientiﬁc and ethical problems to be over-
come before such a control strategy could be implemented.
Materials and Methods
Mosquitoes, animals, and parasites. A. stephensi mosquito strain
SDA 500 was maintained at Jichi Medical University and Imperial
College London. Female BALB/c mice were obtained from SEASCO
(Saitama, Tokyo, Japan) and used at 7 to 8 weeks of age. Female brown
Norway rats were obtained from SEASCO and used at 7 to 8 weeks of
age. P. berghei strain ANKA 234 was maintained by cyclical passage
through Balb/c mice and A. stephensi using standard methods [35]. P.
falciparum strain 3D7 was maintained in asynchronous culture as
described elsewhere [36].
Hemolytic and hemagglutination and assay. CEL-III was puriﬁed
from C. echinata body ﬂuid as previously described [22]. Hemolytic
activity was measured in the absence or presence of 5% FBS either by
visual examination of lysis of erythrocytes or by measurement of
hemoglobin release from erythrocytes using absorbance at 540 nm, as
previously described [24]. Hemagglutination activity of CEL-III
toward human, mouse, and rat erythrocytes was measured in the
presence of 10% Dextran 4 (an osmotic protectant: SERVA,
Heidelberg, Germany) as previously described [19].
In vitro ookinete inhibition assay. P. berghei–infected mouse blood
was diluted in 5 vol ookinete medium (RPMI 1640, 10% FCS, 50 lg/ml
hypoxanthine, 0.024 M NaHCO3,5lg/ml penicillin and 5 lg/ml
streptomycin, ﬁnal pH 8.3) in 24-well plates with different concen-
trations of CEL-III and control containing the same buffer. The plate
was then incubated at 19 8C on a slow moving shaker for 24 h. After
24 h, the culture was then smeared and ﬁxed with methanol. Air-
dried slides were stained with Giemsa, and then the number of
ookinetes was counted in a sample of 2,000 or 5,000 RBCs.
Binding of CEL-III to erythrocytes and ookinetes. Mouse and rat
erythrocytes were prepared from whole bloods by washing ﬁve times
with PBS. In vitro cultured ookinetes were puriﬁed as previously
described [37]. Mouse erythrocytes, rat erythrocytes, or ookinetes
were incubated with 25 lg/ml of CEL-III at room temperature for 1 h
in PBS, and then washed ﬁve times with PBS. Bound CEL-III was
detected by ﬂuorescence microscopy with goat FITC-labeled anti-
mouse IgG (Biosource) following mouse anti-CEL-III antiserum [19].
Minos vector construction and germline transformation. PCR
reactions were performed with Pfu DNA polymerase (Stratagene
GmbH). A gene fragment encoding amino acids 11–342 of CEL-III
was ampliﬁed from plasmid pGEM-CEL-III [38] by PCR using primers
pCEL-III-F1 and -R1 (Table S1). The PCR product was cloned into
pENTR/D-TOPO (Invitrogen) to generate pENTR-CEL-III. A 2,311-bp
DNA fragment of the putative promoter region of the AgCPA gene
and its signal sequence was obtained from A. gambiae genomic DNA by
PCR using primers pAgCPA-F2 and -R2 (Table S1). A 392-bp DNA
fragment of the putative terminator region of Antryp1 [39] was
obtained from A. gambiae genomic DNA by PCR using primers
pAgAntrp1-F1 and -R1 (Table S1). The AgCPA promoter and Antryp1
terminator were assembled by overlapping PCR using primers
pAgCPA-F2 and pAgAntrp1-R1, then cloned into pENTR/D-TOPO
(Invitrogen) to generate pENTR-carboxypeptidaseP-antryp1T. The
gene fragment encoding CEL-III was excised from pENTR-CEL-III by
digestion with BglII and SphI, then cloned into the BamHI/SphI sites
of pENTR-carboxypeptidaseP-antryp1T to generate plasmid pENTR-
carboxypeptidaseP CEL-III-antryp1T. Transformation plasmid pMi-
nos-EGFP-carboxypeptidaseP-CELIII-antryp1T was generated by in-
cubation of pMinos-EGFP-RfA-F [4] and pENTR-carboxypeptidaseP-
CELIII-antryp1T in the presence of LR Clonase (Invitrogen) accord-
ing to the manufacturer’s instructions. Primer sequence information
is available in Table S1.
Embryo microinjection of the transformation and helper plasmids,
screening of EGFP-expressing G0-G2 larvae, and generation of a
homozygous line were performed as previously described [4].
RT-PCR. We have cloned and sequenced a gene fragment
encoding a part of the AsCPA gene from the midgut mRNA of A.
stephensi by RT-PCR using primers, pAgCPA-F1 and pAgCPA-R1
(Table S1), designed for the AgCPA gene. Total RNA was isolated from
mosquito midguts using an RNeasy Mini column (Qiagen). Gene-
speciﬁc primers for the CEL-III, AsCPA, and ribosomal protein S7
genes were pCEL3-RT-F1/pCEL3-R2, pAsCPA-F1/pAsCPA-R1, and
pAgS7-F1/pAgS7-R1, respectively (Table S1). Aliquots of cDNA
representing 0.2 lg total RNA were ampliﬁed by PCR using the
primer sets for detection of these genes. PCR products were
separated by electrophoresis on a 2% agarose gel then visualized by
ethidium bromide staining. PCR products of the S7 gene were used as
controls for quality of the different mRNA preparations used in the
RT-PCR analysis.
Hemolytic assay for mosquito midgut contents. Mosquitoes were
offered RPMI1640 medium containing 50% FBS through a Paraﬁlm
membrane warmed to 37 8C with a glass-watered jacket. Six h after
the meal, engorged midguts from 5 mosquitoes were dissected in
TBS-Ca (10 mM Tris-HCl [pH 7.5], 150 mM NaCl and 10 mM CaCl2),
then homogenized in a small volume of TBS-Ca buffer, and
supernatants were removed by centrifugation. The supernatants
were added to human erythrocytes, and then hemolytic activity was
measured by visual examination of lysis of erythrocytes as described
above.
Immunoblot analysis. Mosquitoes were offered protein-free ATP
solution (1 mM ATP, 150 mM NaCl, 10 mM NaHCO3 [pH 7.0])
through a Paraﬁlm membrane warmed to 37 8C with a glass-watered
jacket. This protein-free ATP solution was used to minimize back-
ground in subsequent western blots as previously described [25].
Engorged midguts were dissected 6 or 24 h after the meal in
phosphate buffered saline (PBS), then solubilized with Laemmli
buffer containing 1% 2-mercaptoethanol. The equivalent of 2 guts
was separated on an 8% SDS-PAGE, electroblotted to Immobilon
Transfer Membrane (Millipore), then probed with mouse anti-CEL-III
polyclonal antibody. Bound antibodies were subsequently detected as
previously described [5]. Native CEL-III was used for quantiﬁcation of
CEL-III expression per gut.
Histology of midgut sections. Mosquitoes were allowed to feed on a
healthy Japanese volunteer. 24 h after a blood meal, engorged
mosquitoes were ﬁxed with 10% buffered formalin, then embedded
Table 5. P. falciparum Gametocyte Membrane Feeding Experiments
Experiment Mosquitoes Prevalence
a TBp
b Number Oocysts/Gut
c (Range) TBi
d
1 Control 68.0% (34/50) — 7.7 6 8.8 (0–28) —
CEL-III 56.5% (48/85) 17.0% 1.8 6 2.5 (0–11) 76.6%
e
2 Control 30.0% (15/50) — 0.7 6 1.4 (0–6) —
CEL-III 26.0% (13/50) 13.3% 0.3 6 1.6 (0–3) 57.1%
Average Control 49.0% (49/100) — 4.2 6 7.2 (0–28) —
CEL-III 45.2% (61/135) 7.8% 1.3 6 2.1 (0–11) 69.1%
e
Transgenic (CEL-III) and non-transgenic (Control) mosquitoes were fed on P. falciparum gametocyte culture by membrane feeding. On day 10, the guts were dissected and the number of
oocysts per gut was determined.
a, b, c, dPrevalence, TBp, intensity, and TBi are described as Table 1.
eStatistical significance (p , 0.05), as calculated by the Mann-Whitney U test.
doi:10.1371/journal.ppat.0030192.t005
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stained with HE. The Japanese volunteer gave his written consent to
be included in this study after detailed explanation of the research
project.
Oocyst inhibition assay for P. berghei. Transgenic and sibling non-
transgenic mosquitoes were mixed in the same container then
allowed to feed on a single infected rat or mouse. Blood-fed
mosquitoes were separated after 24 h, then sorted into transgenic
and non-transgenic mosquitoes using a ﬂuorescence stereomicro-
scope SZX7 (Olympus) with GFP ﬁlter (excitation/emission at 480 nm/
515 nm). Expression of EGFP in the abdomen of transgenic
mosquitoes allowed them to be distinguished from non-transgenic
mosquitoes. The two species of mosquitoes were separately housed in
pots at 21 8C with 5% fructose solution. On day 15, midguts were
dissected, then number of oocysts per midgut was determined.
Prevalence, TBp, the mean number of oocysts in the midgut
(intensity), and TBi were calculated as previously described [5,40].
Data were analyzed using the Mann-Whitney U test.
Oocyst inhibition assay for P. falciparum. Mature gametocytes of P.
falciparum (3D7) were produced in vitro as previously described [41].
Membrane feeding assays were performed to test infectivity of the P.
falciparum gametocytes for mosquitoes as previously described [42].
Brieﬂy, mature gametocyte cultures (0.3 to 0.4% ﬁnal gametocytemia)
were fed for 30 min at 37 8C to transgenic and non-transgenic
mosquitoes through a Paraﬁlm membrane. Engorged mosquitoes
were housed in pots at 26 8C and 60%–80% relative humidity. On day
10, midguts were dissected and number of oocysts per midgut was
determined. The prevalence was analyzed as above.
Sporozoite transmission assay. Transgenic and non-transgenic
mosquitoes were allowed to feed on the same rat, which was infected
with P. berghei. Mosquitoes that blood-fed (30 transgenic and 60 non-
transgenic mosquitoes) were separated after 24 h and housed in pots
at 218C with 5% fructose solution. To measure transmission, 6
mosquitoes per group were allowed to feed on individual naı ¨ve mice
21 days after ingesting the infectious blood meal. Of 6 mosquitoes, at
least 3 mosquitoes were observed to feed on each mouse. Immediately
after a blood meal, engorged mosquitoes (20 of 30 transgenic and all
60 non-transgenic mosquitoes) were picked up and the salivary glands
were excised, placed on a microscope slide, squashed under a cover
slip, and then examined by phase-contrast microscopy (3 400).
Numbers of sporozoites per salivary gland (intensity) was determined
using a gland index based on Collins et al. (1977) [43]: 0; 1: 1–499; 2;
500–4,999; 3: . 5,000. The infection status of each mouse was
established by examining a smear of tail blood on alternate days. Mice
that had no parasites by day 30 were considered to be uninfected.
Supporting Information
Table S1. Primer Sequences
Found at doi:10.1371/journal.ppat.0030192.st001 (40 KB DOC).
Accession Numbers
The GenBank (http://www.ncbi.nlm.nih.gov/Genbank/) accession num-
bers for the genes discussed in this paper are AsCPA (AB353072) and
CEL-III (AB109017).
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